|       |   |                                                                                     |
|------------|--------|------------------------------------------------------------------------------------------|
| (Mark One) |   |                                                                                     |
|       |   |                                                                                     |
| þ     |   | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

|   |   |                                                                                      |
|--------|--------|-------------------------------------------------------------------------------------------|
|   |   |                                                                                      |
| o      |   | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

|                                                         |
|--------------------------------------------------------------|
| CELLULAR CONCRETE TECHNOLOGIES, INC.                         |
| (Exact name of registrant as specified in its charter)  |

|                                           |   |                              |
|------------------------------------------------|--------|-----------------------------------|
| Delaware                                       |   | 45-4511068                        |
| (State or other jurisdiction of incorporation) |   | (IRS Employer Identification No.) |
|                                           |   |                              |

|                      |   |                |   |                    |   |                             |
|---------------------------|--------|---------------------|--------|-------------------------|--------|----------------------------------|
| Large Accelerated Filer o |   | Accelerated Filer o |   | Non-Accelerated Filer o |   | Smaller Reporting Company þ |
|                      |   |                |   |                    |   |                             |

----

|                                  |                                                                                                                                                                                   |   |    |   |   |
|---------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|---------|--------|--------|
|                                  |                                                                                                                                                                                   |   | Page(s) |   |
| PART I – FINANCIAL INFORMATION: |                                                                                                                                                                                   |   |    |
|                                  |                                                                                                                                                                                   |   |    |   |
| Item 1.                               | Financial Statements (unaudited):                                                                                                                                                      |   |    | 3      |   |
|                                  |                                                                                                                                                                                   |   |    |   |   |
|                                  | Balance Sheets as of September 30, 2013 (unaudited) and March 31, 2013 (audited)                                                                                                       |   |    | 3      |   |
|                                  |                                                                                                                                                                                   |   |    |   |   |
|                                  | Statements of Operations for the three and six months ended September 30, 2013 and 2012  and period from inception (February 6, 2012) through September 30, 2013 (unaudited) |   |    | 4      |   |
|                                  |                                                                                                                                                                                   |   |    |   |   |
|                                  | Statements of Cash Flows for the six months ended September 30, 2013and 2012 and period from inception (February 6, 2012) through September 30, 2013 (unaudited)                  |   |    | 5      |   |
|                                  |                                                                                                                                                                                   |   |    |   |   |
|                                  | Notes to Financial Statements (unaudited)                                                                                                                                              |   |    | 6      |   |
|                                  |                                                                                                                                                                                   |   |    |   |   |
| Item 2.                               | Management's Discussion and Analysis of Financial Condition and Results of Operations                                                                                                  |   |    | 10     |   |
|                                  |                                                                                                                                                                                   |   |    |   |   |
| Item 3.                               | Quantitative and Qualitative Disclosures About Market Risk                                                                                                                             |   |    | 11     |   |
|                                  |                                                                                                                                                                                   |   |    |   |   |
| Item 4T                               | Controls and Procedures                                                                                                                                                                |   |    | 12     |   |
|                                  |                                                                                                                                                                                   |   |    |   |   |
| PART II – OTHER INFORMATION:    |                                                                                                                                                                                   |   |    |   |
|                                  |                                                                                                                                                                                   |   |    |   |   |
| Item 1.                               | Legal Proceedings                                                                                                                                                                      |   |    | 13     |   |
|                                  |                                                                                                                                                                                   |   |    |   |   |
| Item 1A                               | Risk Factors                                                                                                                                                                           |   |    | 13     |   |
|                                  |                                                                                                                                                                                   |   |    |   |   |
| Item 2.                               | Unregistered Sales of Equity Securities and Use of Proceeds                                                                                                                            |   |    | 13     |   |
|                                  |                                                                                                                                                                                   |   |    |   |   |
| Item 3.                               | Defaults Upon Senior Securities                                                                                                                                                        |   |    | 13     |   |
|                                  |                                                                                                                                                                                   |   |    |   |   |
| Item 4.                               | (Reserved and Removed)                                                                                                                                                                 |   |    | 13     |   |
|                                  |                                                                                                                                                                                   |   |    |   |   |
| Item 5.                               | Other Information                                                                                                                                                                      |   |    | 13     |   |
|                                  |                                                                                                                                                                                   |   |    |   |   |
| Item 6.                               | Exhibits                                                                                                                                                                               |   |    | 14     |   |
|                                  |                                                                                                                                                                                   |   |    |   |   |
|                                  | Signatures                                                                                                                                                                             |   |    | 14     |   |

----

|                                                                                                                                                                                                                      |   |          |    |   |      |   |    |   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|---------------|---------|--------|-----------|--------|---------|--------|
|                                                                                                                                                                                                                      |   | September 30, |    |   | March 31, |   |
|                                                                                                                                                                                                                      |   | 2013          |    |   | 2013      |   |
|                                                                                                                                                                                                                      |   |          |    |   |      |   |
| ASSETS                                                                                                                                                                                                                    |   |          |    |   |      |   |    |   |
| Current assets:                                                                                                                                                                                                           |   |          |    |   |      |   |    |   |
|         Cash and cash equivalents                                                                                                                                                 |   | $             | -       |   |      | $      | -       |   |
|                                                                                                                                                                                                                      |   |          |    |   |      |   |
|                                                                                                                                                                                                                      |   |          |    |   |      |   |    |   |
|                                                                                                                                                                                                                      |   | $             | -       |   |      | $      | -       |   |
|                                                                                                                                                                                                                      |   |          |    |   |      |   |
| LIABILITIES AND STOCKHOLDERS’ DEFICIT                                                                                                                                                                               |   |          |    |   |      |   |    |   |
|        Current liabilities:                                                                                                                                                            |   |          |    |   |      |   |    |   |
|        Accrued expenses due to founder                                                                                                                                                 |   | $             | 8,631   |   |      | $      | 6,415   |   |
|        Bank overdraft                                                                                                                                                                  |   |          |    |   |      |   | 16      |   |
|                                                                                                                                                                                                                      |   |          |    |   |      |   |
|        Total liabilities                                                                                                                                                               |   |          | 8,631   |   |      |   | 6,431   |   |
|                                                                                                                                                                                                                      |   |          |    |   |      |   |
|        Commitments and contingencies                                                                                                                                                   |   |          |    |   |      |   |    |   |
|                                                                                                                                                                                                                      |   |          |    |   |      |   |    |   |
|        Stockholders’ deficit:                                                                                                                                                    |   |          |    |   |      |   |    |   |
|                                                                                                                                                                                                                      |   |          |    |   |      |   |    |   |
|        Common stock, 100,000,000 shares authorized (par value $.0001) 26,350,000 and 5,000,000 shares issued and outstanding as of September 30, 2013 and March 31, 2013, respectively |   |          | 2,635   |   |      |   | 2,635   |   |
|        Additional paid-in capital                                                                                                                                                      |   |          | 1,500   |   |      |   | 1,500   |   |
|        Deficit accumulated during the development stage                                                                                                                                |   |          | (12,766 | )      |      |   | (10,566 | )      |
|                                                                                                                                                                                                                      |   |          |    |   |      |   |
|        Total stockholders’ deficit                                                                                                                                               |   |          | (8,631) |   |      |   | (6,431) |   |
|                                                                                                                                                                                                                      |   |          |    |   |      |   |
|  TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT                                                                                                                                                                         |   | $             | -       |   |      | $      |    |   |

----

|                             |   |                      |       |                                                          |   |          |      |   |       |   | February 6, 2012 |
|----------------------------------|--------|---------------------------|------------|---------------------------------------------------------------|--------|---------------|-----------|--------|------------|--------|------------------|
|                             |   |                      |       |                                                          |   |          |      |   |       |   | (inception)      |
|                             |   | Three Month Periods Ended |       | Six Months Period Ended                                       |   | through       |
|                             |   | September 30,             |       |         September 30, |   | September 30, |
|                             |   | 2013                      |       |                                                          | 2012   |          | 2013      |   | 2012       |   | 2013             |
|                             |   |                      |       |                                                          |   |          |      |   |       |   |             |
| Revenues                         |   |                      | -          |                                                          |   |          | -         |   | -          |   | -                |   |   | - |
|                             |   |                      |       |                                                          |   |          |      |   |       |   |             |   |   |   |
| EXPENSES                         |   |                      |       |                                                          |   |          |      |   |       |   |             |   |   |   |
| Operating Expenses               |   |                      |       |                                                          |   |          |      |   |       |   |             |   |   |   |
| General and administrative       |   | $                         | 1,100      |                                                          |   | $             | 1,800     |   | 2,200      |   | 2,400            |   | $ | 12,766 |
| Total operating expenses         |   |                      | 1,100      |                                                          |   |          | 1,800     |   | 2,200      |   | 2,400            |   |   | 12,766 |
|                             |   |                      |       |                                                          |   |          |      |   |       |   |             |   |   |   |
| NET LOSS                         |   | $                         | (1,100)    |                                                          |   | $             | (1,800)   |   | (2,200)    |   | (2,400)          |   | $ | (12,766) |
|                             |   |                      |       |                                                          |   |          |      |   |       |   |             |   |   |   |
|                             |   |                      |       |                                                          |   |          |      |   |       |   |             |   |   |
| BASIC AND DILUTED LOSS PER SHARE |   | $                         | (0.00)     |                                                          |   | $             | (0.00)    |   | (0.00)     |   | (0.00)           |   |   |   |   |
|                             |   |                      |       |                                                          |   |          |      |   |       |   |             |   |   |   |   |
| WEIGHTED AVERAGE NUMBER OF       |   |                      |       |                                                          |   |          |      |   |       |   |             |   |   |   |   |
| SHARES OUTSTANDING               |   |                      | 26,350,000 |                                                          |   |          | 5,000,000 |   | 26,350,000 |   | 5,000,000        |   |   |   |   |

----

| CELLULAR CONCRETE TECHNOLOGIES, INC.                                              |   |
|-----------------------------------------------------------------------------------|--------|
| ( A Development Stage Company)                                                    |   |
| STATEMENTS OF CASH FLOWS(Unaudited)                                               |   |
|                                                                              |   |
|                                                                              |   | For the six months ending September 30, 2013 |   |   | For the six months endingSeptember 30, 2012 |   |   | Inception(February 6, 2012)through September 30, 2013 |   |
|                                                                              |   |   |   |   |   |   |   |   |   |
| CASH FLOW FROM OPERATING ACTIVITIES                                               |   |   |   |   |   |   |   |   |   |
|                                                                              |   |   |   |   |   |   |   |   |   |
| Net loss                                                                          |   | $ | (2,200 | ) |   | $ | (2,400 | ) |   | $ | (12,766 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities        |   |   |   |   |   |   |   |   |   |   |   |   |
|     Issuance of common stock under consulting agreement       |   |   | - |   |   |   | - |   |   |   | 150 |   |
| Change in Assets & Liabilities                                                |   |   |   |   |   |   |   |   |   |   |   |   |
|     Accrued payroll and other liabilities                     |   |   | 2,200 |   |   |   | 2,400 |   |   |   | 8,631 |   |
|     Change in bank overdraft                                  |   |   | - |   |   |   | - |   |   |   | - |   |
| Net Cash used in operations                                                       |   |   | - |   |   |   | - |   |   |   | (3,985 | ) |
|                                                                              |   |   |   |   |   |   |   |   |   |   |   |   |
| CASH FLOW FROM FINANCING ACTIVITIES                                               |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                              |   |   |   |   |   |   |   |   |   |   |   |   |
|     Tender of shares by founder                               |   |   | - |   |   |   | - |   |   |   | (350 | ) |
|     Proceeds from stock issuance under subscription agreement |   |   | - |   |   |   | - |   |   |   | 4,335 |   |
| Net Cash provided by financing activities                                         |   |   |   |   |   |   |   |   |   |   | 3,985 |   |
|                                                                              |   |   |   |   |   |   |   |   |   |   |   |   |
| Net increase (decrease) in cash                                                   |   |   |   |   |   |   |   |   |   |   | - |   |
|                                                                              |   |   |   |   |   |   |   |   |   |   |   |   |
| Cash at the Beginning of the Period                                               |   |   | - |   |   |   | 200 |   |   |   | - |   |
| Cash at the End of the Period                                                     |   | $ | - |   |   | $ | 200 |   |   | $ | - |   |

----

|   |                       |
|--------|----------------------------|
| (a)    | Organization and Business: |

|   |                                                       |
|--------|------------------------------------------------------------|
| (b)    | Basis of Presentation- development stage and going concern |

|   |              |
|--------|-------------------|
| (c)    | Use of Estimates: |

|   |                      |
|--------|---------------------------|
| (d)    | Cash and Cash Equivalents |

----

|   |                  |
|--------|-----------------------|
| (e)    | Loss per Common Share |

|   |                                            |
|--------|-------------------------------------------------|
| (f)    | Fair Value of Financial Instruments   |

|          |                                                                                                                                                                                                                                                                                                                             |   |   |
|---------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|
| -   | Level 1:  Quoted prices in active markets for identical assets or liabilities.                                                                                                                                                                                                                                         |
| -   | Level 2:  Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities. |
| -   | Level 3:  Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.                                                                                                                                                              |
| (g)           | Recent Accounting Pronouncements- Adopted                                                                                                                                                                                                                                                                                        |   |

----

|    |                                                                                                                                                                                                          |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| ● | Milestone 1 – Company’s right of repurchase will lapse with respect to 60% of the shares upon securing $2.5 million in available cash from funding;                                          |
| ● | Milestone 2 – Company’s right of repurchase will lapse with respect to 40% of the Shares upon securing $5 million in available cash (inclusive of any amounts attributable to Milestone 1);  |

----

|                      |   |                         |     |   |          |    |     |   |
|---------------------------|--------|------------------------------|----------|--------|---------------|---------|----------|--------|
|                      |   | September 30,2013(Unaudited) |     |   | March 31,2013 |    |
| Gross deferred tax assets |   | $                            | 12,766   |   |          | $       | 10,566   |   |
| Valuation allowance       |   |                         | (12,766) |   |          |    | (10,566) |   |
| Net deferred tax asset    |   | $                            | —  |   |          |  $ | —  |   |

----

----

|                 |   |   |    |   |
|----------------------|--------|--------|---------|--------|
| Operating activities |   | $      | (3,985) |   |
| Investing activities |   |   | -       |   |
| Financing activities |   | $      | 3,985   |   |
|                 |   |   |    |   |
| Net effect on cash   |   | $      | -       |   |

----

----

----

|        |   |                                                                                                                                                                                                                                       |
|-------------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Exhibit No. |   | Description                                                                                                                                                                                                                                |
|        |   |                                                                                                                                                                                                                                       |
| 31.1        |   | Certification of the Company’s Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2013. |
|        |   |                                                                                                                                                                                                                                       |
| 31.2        |   | Certification of the Company’s Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2013. |
|        |   |                                                                                                                                                                                                                                       |
| 32.1        |   | Certification of the Company’s Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.                                 |
| 101.DEF     |   | XBRL Taxonomy Extension Definition Linkbase Document                                                                                                                                                                                       |
| 101.INS     |   | XBRL Instance Document                                                                                                                                                                                                                     |
| 101.SCH     |   | XBRL Taxonomy Extension Schema Document                                                                                                                                                                                                    |
| 101.CAL     |   | XBRL Taxonomy Extension Calculation Linkbase Document                                                                                                                                                                                      |
| 101.LAB     |   | XBRL Taxonomy Extension Label Linkbase Document                                                                                                                                                                                            |
| 101.PRE     |   | XBRL Taxonomy Extension Presentation Linkbase Document                                                                                                                                                                                     |
| 101.DEF     |   | XBRL Taxonomy Extension Definition Linkbase Document                                                                                                                                                                                       |

|                    |                                 |           |   |
|-------------------------|--------------------------------------|----------------|--------|
| Dated: January 22, 2014 |                                 |           |   |
|                    | CELLULAR CONCRETE TECHNOLOGIES, INC. |           |
|                    |                                 |           |   |
|                    | By:                                  | /s/ Paul Falco |   |
|                    | Paul Falco                           |           |
|                    | President/ CEO                       |           |

----

|        |   |                                                                                                                                                                                                                                       |
|-------------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Exhibit No. |   | Description                                                                                                                                                                                                                                |
|        |   |                                                                                                                                                                                                                                       |
| 31.1        |   | Certification of the Company’s Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2013. |
|        |   |                                                                                                                                                                                                                                       |
| 31.2        |   | Certification of the Company’s Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2013. |
|        |   |                                                                                                                                                                                                                                       |
| 32.1        |   | Certification of the Company’s Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.                                 |
| 101.DEF     |   | XBRL Taxonomy Extension Definition Linkbase Document                                                                                                                                                                                       |
| 101.INS     |   | XBRL Instance Document                                                                                                                                                                                                                     |
| 101.SCH     |   | XBRL Taxonomy Extension Schema Document                                                                                                                                                                                                    |
| 101.CAL     |   | XBRL Taxonomy Extension Calculation Linkbase Document                                                                                                                                                                                      |
| 101.LAB     |   | XBRL Taxonomy Extension Label Linkbase Document                                                                                                                                                                                            |
| 101.PRE     |   | XBRL Taxonomy Extension Presentation Linkbase Document                                                                                                                                                                                     |
| 101.DEF     |   | XBRL Taxonomy Extension Definition Linkbase Document                                                                                                                                                                                       |

----

----